These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22890523)

  • 1. Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group.
    Bieglmayer C; Dimai HP; Gasser RW; Kudlacek S; Obermayer-Pietsch B; Woloszczuk W; Zwettler E; Griesmacher A
    Wien Med Wochenschr; 2012 Nov; 162(21-22):464-77. PubMed ID: 22890523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated approach for the management of osteoporosis in Turkey: a consensus report.
    Kirazlı Y; Atamaz Çalış F; El Ö; Gökçe Kutsal Y; Peker Ö; Sindel D; Tuzun Ş; Gogas Yavuz D; Durmaz B; Akarirmak Ü; Bodur H; Hamuryudan V; Inceboz U; Öncel S
    Arch Osteoporos; 2020 Aug; 15(1):137. PubMed ID: 32860546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
    Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ;
    N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.
    Duarte MP; Farias ML; Coelho HS; Mendonça LM; Stabnov LM; do Carmo d Oliveira M; Lamy RA; Oliveira DS
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1022-7. PubMed ID: 11595067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.
    Galindo-Zavala R; Bou-Torrent R; Magallares-López B; Mir-Perelló C; Palmou-Fontana N; Sevilla-Pérez B; Medrano-San Ildefonso M; González-Fernández MI; Román-Pascual A; Alcañiz-Rodríguez P; Nieto-Gonzalez JC; López-Corbeto M; Graña-Gil J
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):20. PubMed ID: 32093703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
    Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
    J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and Silent Vertebral Fractures in Nursing Home Resident Elderly Men in Turkey.
    Kucukler FK; Simsek Y; Turk AÇ; Arduc A; Guler S
    J Clin Densitom; 2017; 20(2):188-195. PubMed ID: 26071170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
    Geller JL; Hu B; Reed S; Mirocha J; Adams JS
    Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study.
    Nakamura Y; Kamimura M; Ikegami S; Mukaiyama K; Uchiyama S; Taguchi A; Kato H
    BMC Endocr Disord; 2015 Dec; 15():81. PubMed ID: 26666998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of vitamin D deficiency and its correlation with PTH, biochemical bone turnover markers and bone mineral density, among patients from ambulatories].
    Silva BC; Camargos BM; Fujii JB; Dias EP; Soares MM
    Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):482-8. PubMed ID: 18506273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
    Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
    Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status.
    Mok J; Brown C; Moore AEB; Min SS; Hampson G
    Endocr Res; 2018 Aug; 43(3):195-202. PubMed ID: 29652557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden.
    Eom SY; Yim DH; Hong SM; Kim YD; Kim H; Choi BS; Park JD; Park CH; Kim GB; Yu SD
    Hum Exp Toxicol; 2018 Apr; 37(4):350-357. PubMed ID: 28441892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up.
    Pavón de Paz I; Rosado Sierra JA; Pérez Blanco C; Modroño Móstoles N; Guijarro de Armas G; Navea Aguilera C
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):108-116. PubMed ID: 30077631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.
    Fojas MC; Southerland LT; Phieffer LS; Stephens JA; Srivastava T; Ing SW
    Arch Osteoporos; 2017 Dec; 12(1):16. PubMed ID: 28155141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.